Mark Zuckerberg and wife Dr. Priscilla Chan recently announced a $3 billion initiative geared towards curing most of the world’s diseases called the Biohub. Through the Chan Zuckerberg Initiative, the couple managed to draw support from other billionaires and ordinary people alike in terms of funding and cooperation. Recently, the Facebook founder released a post detailing how a meeting with top scientists gave him hope that most, if not all of the world’s diseases will be gone by 2115.
The scientists in question are at the top of their fields with regards to dealing with illnesses and they come from multiple origins, including Stanford University and UC Berkeley. Heading the team is Dr. Cori Bargmann, who is a Rockefeller neuroscientist, Futurism reports.
Even with excellent brains behind the operation, the goal of eradicating even just a majority of the known diseases plaguing the world is a monumental undertaking. Much of the challenges has to do with research, which is a costly and time-consuming affair. The Biohub will take on a lot of the weight of the problems that usually prevent scientists from making swift progress, but even then, many would consider the 100-year timeline to be overly ambitious.
Zuckerberg and the team of scientists don’t seem to think so, however, and they point to the advancements that humanity has achieved in the last few decades in extending human lifespan. Global Futurist also notes how the initiative has already addressed one of the hurdles of getting to the point that they are aiming for; coordination.
There’s also the matter of the most recent innovations in medical and bioresearch to consider, which gives the lofty goals of a disease-free world a boost. There’s the new gene-editing tool called CRISPR, which is basically a starter kit for playing God. Then there’s the project called Cell Atlas, which aims to map all of the human body’s cells to address diseases that begin at the cellular level.


Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine
Britain Courts Anthropic Amid US Defense Department Dispute
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers
CDC Acting Director Urges Measles Vaccination as U.S. Cases Surge in 2026
Intermittent fasting doesn’t have an edge for weight loss, but might still work for some
Microsoft's $10 Billion Japan Investment: AI Infrastructure and Data Sovereignty Push
Makemation: a Nollywood movie that shows AI in action in Africa
RFK Jr. Overhauls Federal Autism Panel, Sparking Medical Community Backlash
Viking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug Market
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
California's AI Executive Order Pushes Responsible Tech Use in State Contracts
Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s
NASA Artemis II: First Crewed Moon Mission Since Apollo Takes Four Astronauts on 10-Day Lunar Journey
Moderna to Pay Up to $2.25B to Settle LNP Patent Dispute Over COVID-19 Vaccine Technology
Sanofi Gains China Approval for Myqorzo and Redemplo, Strengthening Rare Disease Portfolio
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal 



